ExploreWatchlistsPricing
  1. US-listed companies
  2. Cyclo Therapeutics, Inc.
  3. Financials
  4. Pretax margin (%)

Cyclo Therapeutics, Inc. (CYTH)

Market cap
$20.73M
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 2023-1,863.4+65.92%
Dec 31, 2022-1,123.1+24.66%
Dec 31, 2021-900.9-8.98%
Dec 31, 2020-989.8+32.35%
Dec 31, 2019-747.9+77.78%
Dec 31, 2018-420.7+35.84%
Dec 31, 2017-309.7+10.19%
Dec 31, 2016-281+9.86%
Dec 31, 2015-255.8+576.53%
Dec 31, 2014-37.8-324.74%
Dec 31, 201316.8+77.23%
Dec 31, 20129.5-200.20%
Dec 31, 2011-9.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat